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Abstract 
Objective: The validity of current ultra-high risk (UHR) criteria is under-examined in help-seeking 
minors, particularly, in children below the age of 12 years. Thus, the present study investigated 
predictors of one-year outcome in children and adolescents (CAD) with UHR status. 
Method: Thirty-five children and adolescents (age 9–17 years) meeting UHR criteria according to 
the Structured Interview for Psychosis-Risk Syndromes were followed-up for 12 months. 
Regression analyses were employed to detect baseline predictors of conversion to psychosis and of 
outcome of non-converters (remission and persistence of UHR versus conversion). 
Results: At one-year follow-up, 20% of patients had developed schizophrenia, 25.7 % had remitted 
from their UHR status that, consequently, had persisted in 54.3%. No patient had fully remitted 
from mental disorders, even if UHR status was not maintained. Conversion was best predicted by 
any transient psychotic symptom and a disorganized communication score. No prediction model for 
outcome beyond conversion was identified. 
Conclusions: Our findings provide the first evidence for the predictive utility of UHR criteria in 
CAD in terms of brief intermittent psychotic symptoms (BIPS) when accompanied by signs of 
cognitive impairment, i.e. disorganized communication. However, because attenuated psychotic 
symptoms (APS) related to thought content and perception were indicative of non-conversion at 1-
year follow-up, their use in early detection of psychosis in CAD needs further study. Overall, the 
need for more in-depth studies into developmental peculiarities in the early detection and treatment 
of psychoses with an onset of illness in childhood and early adolescence was further highlighted.  
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1 Introduction 
Psychoses are one of the most severe disorders in children and adolescents (CAD) (Gore et al., 
2014). Their poor outcome generally correlates positively with the durations of untreated psychosis 
(DUP) and illness (DUI) (Marshall et al., 2005). Outcome is even worse in early-onset psychosis 
(EOP), with the first episode starting before the age of 18 years (Rabinowitz et al., 2006).  
 
1.1  Early-onset psychoses 
Compared with adult-onset psychosis (AOP), the poorer outcome of EOP might not be intrinsic, but 
due to a significantly longer DUP (Schimmelmann et al., 2007, 2008). Furthermore, clinically, EOP 
often presents slightly differently compared with AOP (Gochman et al., 2011; Tiffin et al., 2013). 
Thus, the challenges of early detection and treatment of first signs of the emerging disorder may be 
different in EOP and also in AOP with an illness onset in childhood and early adolescence 
compared with AOP that has an onset in late adolescence and adulthood (Schimmelmann & 
Schultze-Lutter, 2012; Schimmelmann et al., 2013).  
 
1.2 Early detection of psychosis in children and adolescents 
Two approaches for an early detection of psychoses currently prevail: the “ultra-high risk” (UHR) 
(Yung et al., 1998), mainly relying on attenuated psychotic symptoms (APS) and the “basic 
symptoms” (Schultze-Lutter et al., 2012). The alternative UHR criteria, which comprise the 
attenuated psychotic symptom (APS) criterion, the brief intermittent psychotic symptom (BIPS) 
criterion, and the genetic risk and functional decline (GRFD) criterion, were originally developed 
with the explicit aim of detecting an imminent risk for psychoses, i.e., persons at risk for developing 
a first-episode within the next 12 months (Schultze-Lutter et al., 2015). In contrast to the UHR 
criteria, the criteria based on basic symptoms, i.e., the cognitive-perceptive basic symptoms, 
(COPER) criterion and the cognitive disturbances (COGDIS) criterion (Schultze-Lutter et al., 
2012), were developed to detect the risk for psychosis as early as possible in the development of the 
illness, ideally before functional impairments have appeared (Schultze-Lutter et al., 2015).  
A recent meta-analysis showed pooled conversion rates in UHR samples that increased from 9.6% 
at 6 months to 37.0% at >4-year follow-up, with significantly lower conversion rates in 12- to 18-
year-olds (Schultze-Lutter et al., 2015). Lower conversion rates in CAD might not be surprising as 
current risk criteria were developed and validated in predominately adult samples (age ≥ 16 years; 
Schultze-Lutter et al., 2015; Yung et al., 1998).  
CAD studies reporting high prevalence of (attenuated) psychotic symptoms (hallucinations) in the 
general population further indicated age-related peculiarities of UHR symptoms (Schimmelmann et 
al., 2013). These seem to decrease throughout adolescence (Kelleher et al., 2012b; Brandizzi et al., 
2014; Schimmelmann et al., 2015) and remit spontaneously in about three quarters of CAD 
(Bartels-Velthuis et al., 2011).  
Thus, it was recently argued that the validity of current risk criteria needs to be examined in and 
possibly adapted to CAD populations (NICE, 2013; Schimmelmann & Schultze-Lutter, 2012; 
Schimmelmann et al., 2013; Schultze-Lutter et al., 2012, 2015). 
 
1.3  Aims of the study  
To address this need, we investigated predictors of 1-year outcome in CAD at increased risk of 
psychosis in terms of both predictors of conversion to psychosis and of outcome of non-converters 
(remission and persistence of UHR criteria versus conversion).  
 
2  Methods 
2.1 Participants 
The sample consisted of 35 patients (aged 9-17-years, n=7 (20%) each age 9-11 and 16-17) with 
suspected EOP at the Child and Adolescent Neuropsychiatry Unit of the Children Hospital 
Bambino Gesù in Rome from 2012 to 2013 (Table 1). Inclusion criterion was the presence of any 
UHR criterion (Yung et al., 1998): APS, brief intermittent psychotic symptoms (BIPS) and/or 
genetic risk plus functional deterioration (GRFD). Exclusion criteria were: past or present 
psychosis, traumatic brain injury or any known neurological disorder, and current drug or alcohol 
abuse. A history of drug use was permitted if symptoms had also been present in drug-free periods. 
Participants were followed-up for 12 months. 
The study was approved by the Ethics Committee of the Children Hospital Bambino Gesù. All 
participants provided written informed assent and their parents/legal guardians, written informed 
consent.  
Table 1 
 
2.2 Assessments  
UHR criteria and negative, disorganization, and general symptoms were assessed with the 
Structured Interview for Psychosis-Risk Syndromes (SIPS; McGlashan et al., 2010). It was also 
used to assess past or present psychosis at baseline and follow-up, defined by presence of any 
positive symptom rated ‘6’ that is seriously disorganizing or dangerous and/or persists for more 
than 7 days. The type of psychosis was diagnosed using DSM-IV (American Psychiatric 
Association, 1994).  
Mental disorders were assessed using the Schedule for Affective Disorders and Schizophrenia for 
School Aged Children, Present and Lifetime Version (K-SADS-PL; Kaufman et al., 1997); alcohol 
and drug use using sections J and L of the Composite International Diagnostic Interview (CIDI; 
World Health Organization, 1993). Functioning was rated globally on the Childhood Global 
Assessment Scale (CGAS; Schaffer et al., 1988) and differentially on the Global Functioning: 
Social (GF:Social; Auther et al., 2006) and the Global Functioning: Role (GF:Role; Niendam et al., 
2006) scales. Baseline verbal IQ was assessed with the Wechsler Intelligence Scale for Children 
(WISC-III; Wechsler, 1991).  
 
2.3 Data analyses 
Using SPSS 21, predictors of psychosis-conversion were assessed by logistic regression analyses; 
predictors of UHR status remission and persistence versus conversion by ordinal logistic regression 
analyses. Predictors were sociodemographic characteristics (age, gender, education, urbanicity, 
family history of mental disorders) and clinical parameters (main diagnosis, IQ, social and role 
functioning, duration of mental problems, type of UHR criterion, SIPS positive item scores, single 
APS and BIPS, SIPS subscale sum scores). For descriptive purposes, notwithstanding the 
recommended 5:1 relation of number of events to number of predictors (Vittinghoff et al., 2007), 
potential predictors showing at least a trend-level result of p < 0.10 were entered into multivariate 
stepwise logistic and ordinal regression analyses to detect the best, non-redundant predictor(s) of 
outcomes. Furthermore, presence and size of potential age effects on outcome and presence of BIPS 
and APS were examined by kul F² test and Cramer’s V across 2 age groupings (AG1: 9-11, 12-14 
and 15-17 years, and AG2: 9-15 and 16-17 years). 
 
3  Results 
3.1 One-year outcome 
Within 1 year, 7 (20.0%) patients developed an EOP (schizophrenia), while 9 (25.7%) remitted 
from UHR status, which persisted in 19 (54.3%) patients. No significant differences across age 
groups revealed (AG1: F (4)=1.38, p=0.848; AG2: F (2)=1.06, p=0.588), indicating a small age effect 
on outcome (AG1: V=0.140; AG2: V=0.174). Furthermore, neither in general nor on item-level did 
BIPS or APS reveal any significant age group difference at baseline, and a moderate effect only 
revealed for APS in general in AG1 with APS being most frequent in 8-11-year-olds (V=304), and 
for P2-BIPS in AG2 with transient paranoid delusions being most frequent in 16-17-year-olds 
(V=343). 
Most non-converters retained their baseline diagnosis, only one received a different diagnosis. 
Thus, none fully remitted from mental disorders, even if UHR status was not maintained. However, 
only non-converters who remitted from UHR status significantly improved on both GF:Role and 
GF:Social (Wilcoxon tests: Z = -2.333, p = 0.020), while non-converters who maintained UHR 
status also maintained poor functioning. 
 
3.2 Predictors of conversion to psychosis 
In univariate logistic regression analyses, presence of any BIPS and the SIPS-P5 score 
(“disorganized communication”) became significant, while trend-level results were detected for 
absence of any APS, and presence of APS-level SIPS-P5 and BIPS-level SIPS-P4 (“perceptual 
abnormalities/hallucinations”). None of the socio-demographic variables was a significant predictor 
of either conversion to psychosis or remission from UHR status (Table 2).  
TABLE 2 
When entered into the multivariate stepwise model, only any BIPS (E = 2.560, F2(1) = 4.321, p = 
0.052; Exp(E) = 12.937; 95%CI = 0.980 / 170.729) and the SIPS-P5 score (E = 0.740, F2(1) = 4.321, 
p = 0.041; Exp(E) = 2.096; 95%CI = 1.029 / 4.269) were selected into the model by both forward 
and backward methods (Omnibus goodness-of-fit test: F2(2) = 10.557, p = 0.005). 
 
3.3 Predictors of non-psychotic outcome 
In univariate ordinal regression analyses with conversion as poorest outcome and, consequently, as 
reference value, absence of APS-level SIPS-P1 (“unusual thought content/delusional ideas”) and a 
lower SIPS-P5 score were related to better outcome, while an association between better outcome 
and absence of any BIPS, of BIPS-level SIPS-P4 and of APS-level SIPS-P5, a lower SIPS-P sum 
score and presence of any APS was indicated at a trend-level (Table 3). None of these became 
significant, not even on trend-level, in multivariate analyses (Goodness-of-fit: F2(7) = 12.805, p = 
0.077) (Table 4). 
TABLES 3 and 4 
 
4 Discussion 
Addressing the need to examine the validity of UHR criteria in and possibly adapt them to CAD 
(NICE, 2013; Schimmelmann et al. 2013, 2015; Schultze-Lutter et al. 2015), we examined the 1-
year outcome in 35 CAD meeting UHR criteria, thereby including children below the age of 12 for 
the first time. We found a fifth of patients developing psychosis; schizophrenia in all cases. UHR 
status persisted in the majority (54.3%); only a quarter remitted from it within 12 months. However, 
none had remitted from mental problems.  
 4.1 Conversion to psychosis at one-year follow-up 
A recent meta-analysis (Schultze-Lutter et al. 2015) reported lower pooled conversion rates at 1-
year follow-up in CAD UHR samples (9.5%) compared to adult (18.0%) or even mixed age UHR 
samples with a majority of adolescents (20.9%). In light of this, our 20.0% conversion rate seems 
rather high for a CAD sample. 
However, conversion was related to presence of any BIPS, predominately hallucinations and more 
pronounced, yet still attenuated disorganized communication. Though BIPS are usually rare in 
UHR samples, they were related to the significantly highest pooled conversion rate of all 3 UHR 
criteria in the recent meta-analysis (Schultze-Lutter et al., 2015). Thus, their presence – 14.3% in 
our sample and 40.0% in control intervention group in Amminger et al. (2010) – might explain the 
high 1-year conversion rates of 20.0% and 27.5%, respectively, in these 2 CAD samples. 
Accordingly, in adolescent samples with lower conversion rates (3.3-9.7%), BIPS were absent 
(Cornblatt et al., 2007; Lindgren et al., 2014; Welsh and Tiffin, 2014) or only reported by 5.6% 
(Ziermans et al., 2011). Thus, a higher rate of BIPS might be related to a higher conversion rate in 
CAD.  
An association between psychotic symptoms and subsequent psychosis was also reported by the 
Dunedin birth cohort study (Poulton et al., 2000): in the initial absence of a psychotic disorder, 
psychotic symptoms at age 11 predicted development of schizophreniform disorders until the age of 
26. Yet, two other studies (Bartels-Velthuis et al., 2011; Hlastala and McClellan, 2005) with shorter 
follow-ups of 5 and 2 years, respectively, reported high remission rates of psychotic symptoms and 
no conversion to psychosis in CAD. The 5-year follow-up study (Bartels-Velthuis et al., 2011) 
investigated the course of auditory hallucinations in a community sample of 7-8-year-old children. 
The 2-year follow-up study (Hlastala and McClellan, 2005) examined the course of atypical 
psychotic symptoms in 7-18-year-old non-psychotic psychiatric patients. Consequently, the 
applicability of subthreshold or atypical psychotic symptoms for early detection of psychosis in 
CAD was challenged (Hlastala and McClellan, 2005). A feature distinguishing atypical psychotic 
and psychotic symptoms in patients with psychosis was lack of accompanying disorganized 
communication (Hlastala and McClellan, 2005). This agrees with our finding of a higher rating on 
‘disorganized communication’ being an additional predictor of conversion; it might be this co-
occurrence that procured the psychosis-predictive value of BIPS in our sample. Indeed, only the 3 
BIPS patients with a rating of ‘disorganized communication’ ≥2 (i.e., speech that is slightly vague, 
muddled, overelaborated, or stereotyped) converted, while those with a lower rating did not. Yet, 
the comparability of our results with those of these 3 studies is limited by the fact that these studies 
did not use current UHR instruments for the distinction between APS and BIPS and did not assess 
BIPS criteria (i.e., the respective onset and frequency requirements). Thus, CAD with psychotic 
symptoms in these samples most likely only partly represent CAD with BIPS of UHR samples. 
Recently, ‘disorganized speech’ was the only positive item distinguishing converters (13.2%, 
mainly within 1 year) from non-converters in a 14-35-year-old UHR sample with a 2.4-year-follow-
up (Katsura et al., 2014). Furthermore, ‘disorganized communication’ was the sole predictor of 
psychosis in a UHR sample (12-30-year-olds) with a 26% conversion rate at 2.5-year follow-up, 
and suggested as a potential endophenotype or stable trait marker for schizophrenia risk (DeVylder 
et al., 2014). A relationship between communication deviances and 2-year conversion (38.9%) was 
also revealed in speech analyses of mixed-age UHR patients (17 ± 4 years), using audio recordings 
and transcripts (Bearden et al., 2011). This study indicated presence of an impaired use of reasoning 
(illogical thinking) and development of the topic (poverty of content of speech) when formulating 
and organizing thoughts and an under-utilization of linguistic devices necessary for cohesive 
communication prior to the onset of psychosis. 
 
4.2 Attenuated psychotic symptoms and development of psychosis 
Interestingly, absence of any APS – though not selected into the final predictor model of conversion 
– was also suggestive of subsequent conversion in univariate analyses, and, relatedly, presence of 
any APS was suggestive of better outcome in univariate analyses. The majority of APS in our 
sample had occurred for ‘suspiciousness/persecutory ideas’ (77.1%) followed by ‘unusual thought 
content/delusional ideas’ (57.1%) and ‘perceptual aberrations/hallucinations’ (51.4%).  
Earlier studies on an adolescent UHR (Cornblatt et al., 2007) and a mixed-age help-seeking sample 
(Yung et al., 2006) had also reported ‘suspiciousness/persecutory ideas’ as the most frequent 
clinician-assessed APS, and the factor ‘Conceptual Disorganization and Suspiciousness’ was most 
frequent in questionnaire-studies (Armando et al., 2010, 2012, 2013; Brandizzi et al., 2014). 
Persecutory APS, however, had remitted in a considerable proportion of adolescents over the 2-88-
month follow-up period irrespective of type of medication (Cornblatt et al., 2007). Hence, it was 
concluded that seemingly pathological suspiciousness and paranoid ideas of reference (e.g., 
adolescents’ typical report of feeling watched and negatively evaluated by peers) might be more 
prevalent and less predictive of psychosis in adolescents than in adults (Cornblatt et al., 2007). This 
is supported by epidemiological data of 8-40-year-olds that indicated an increase in the clinical 
significance of unusual thought contents, including persecutory ideas, in terms of functional 
impairment with advancing age (Schimmelmann et al., 2015). 
Other community-studies on adolescent UHR patients (Meyer et al., 2005) and CAD (Kelleher et 
al., 2012a,b) reported a preponderance of perceptual APS, potentially decreasing throughout 
adolescence (Kelleher et al., 2012b). In a recent cross-sectional community study of APS, an age-
effect on prevalence revealed solely for ‘perceptual aberrations/hallucinations’ (Schimmelmann et 
al., 2015). Perceptive APS showed a significant shift in prevalence from early to late adolescence, 
i.e., around age 16, and were more frequent in 8-15-year-olds compared to 16-40-year-olds. An 
increased association between APS and psychiatric morbidity across adolescence as suggested by 
Kelleher et al. (2012b) was not confirmed (Schimmelmann et al., 2015). A higher prevalence of the 
self-reported factor ‘Perceptual Abnormalities’ in 11-12-year-olds compared to 17-18-year-olds and 
lack of an association between self-reported attenuated psychotic-like experiences and psychiatric 
morbidity was also reported from a help-seeking CAD sample (Brandizzi et al., 2014).  
Thus, alike BIPS, more research into the differentiation of atypical (i.e., not psychosis-predictive) 
and psychosis-related APS in larger CAD samples and with longer follow-ups is necessary. Longer 
follow-ups will be required to distinguish an actually lesser predictive value of APS from effects of 
a more insidious development of psychosis and a potential extended lag-time-to-conversion in CAD 
as suggested by Cornblatt et al. (2007). 
 
4.3 Predictors of remission of an UHR state 
Our UHR state overall remission rate of 25.7% (i.e., of 32.1% in non-converters) was slightly lower 
than the average overall remission rate of 35.4% (i.e., of 46% in non-converters) reported in a 
recent meta-analysis of mainly mixed-age samples with an average 2-year follow-up (Simon et al., 
2013). However in line with Huber’s notion of outpost syndromes (Schultze-Lutter, 2009), 
symptom fluctuations with only temporary remissions were also observed for UHR criteria (Lee et 
al., 2014; Woods et al. 2014), so that remission – alike non-conversion – at 1-year follow-up must 
be regarded as an intermediate outcome.  
Neither socio-demographic nor clinical variables were found to predict remission; in line with de 
Wit et al. (2014) who also reported that baseline socio-demographic characteristics and clinical 
symptoms did not distinguish between remitters and non-remitters at 6-year follow-up of 44 UHR 
adolescents. Thereby, the most substantial reduction in positive symptoms occurred within the first 
2 years, while improvements in general, mood and anxiety symptoms occurred at a later stage. This 
might explain why most non-converters – even if remitted from UHR status – still suffered from 
mental, mainly affective and anxiety disorders, in particular at short-term follow-ups (Addington et 
al., 2011; de Wit et al., 2014; Haroun et al., 2006; Lemos-Giráldez et al., 2009; Lin et al., 2014).  
However, while all non-converters of our study continued suffering from a mental disorder without 
significant improvement in overall functioning, remitters from UHR status improved in both role 
and social functioning. This is partly in line with the only small 6-year improvement in global 
functioning of 33 adolescent non-converters whose UHR status at follow-up was not reported 
(Ziermans et al., 2014). Yet, a 3-year follow-up study of 77 adolescent non-converters reported 
good role and social functioning outcomes (defined by a score of ‘7’ or higher on GF:Role or 
GF:Social) in at least two thirds that were significantly related to better baseline functioning 
(Carrión et al., 2013), and, consequently, did not necessarily indicate significant functional 
improvement. Thus, functioning in adolescents might be more persistently affected than in older 
UHR samples, as improvement in non-converting mixed adult-adolescent samples within 3-6 years 
were significant, particularly within the first year (Lemos-Giráldez et al., 2009; Velthorst et al., 
2011, 2013). The factors contributing to a lesser functional impairment that might also be related to 
a longer DUI still need to be examined. 
 
4.4 Strengths and limitations 
Our sample differs from other adolescent UHR samples in several aspects: (1) Being recruited at a 
hospital that is an Italian point of reference for the assessment and treatment of psychosis in CAD 
participants had been referred rather on the suspicion of a first episode of EOP than on that of a still 
developing psychosis as is usual when referring to an early detection service. Thus, similar to early 
UHR samples, our sample likely represents a more severe spectrum of the UHR state with high 
rates of BIPS and conversion and is not affected by a risk-dilution effect described for more recent 
samples (Yung et al., 2007), in particular for samples recruited from the community rather than – 
unlike our sample – from mental health services (Fusar-Poli et al., 2015). This sample bias can be 
considered both a strength and limitation of the study. (2) Only 5.6% of our sample had received 
any psychopharmacological treatment at baseline; this rate was much lower than the 41-49% 
medication rate reported by other adolescent UHR samples (Amminger et al., 2010; Carrión et al., 
2013; Lindgren et al., 2014; Ziermans et al., 2011) allowing the observation of a more natural 
course. As any treatment seems to delay or prevent psychosis onset (van der Gaag et al., 2013), this 
low medication rate might have further contributed to both the high rate of BIPS and conversions. 
(3) A certain strength is the absence of any refusals to participate or drop-outs, while (4) the small 
sample size is a certain limitation similar to previous studies (Amminger et al., 2010; Fux et al., 
2013; Lindgren et al., 2014; Welsh and Tiffin, 2014) which prevented a more detailed analysis of 
clinical outcomes. However, our analyses uniquely distinguished between APS- and BIPS-level risk 
symptoms, thereby giving new indications towards possible developmental peculiarities of UHR 
states in CAD. 
 
4.5 Conclusions 
Our findings provide first evidence for the predictive utility of UHR criteria in CAD in terms of 
BIPS when accompanied by signs of cognitive impairment, i.e., disorganized communication. Yet, 
as APS related to both thought content and perception were rather indicative of non-conversion at 
1-year follow-up, their use in early detection of psychosis in CAD needs further study. Overall, the 
need for more in-depth studies into developmental peculiarities in the early detection and treatment 
of psychoses with an onset of illness in childhood and early adolescence was again highlighted. For 
this, it seems necessary to distinguish the predictive utility of risk phenomena (e.g. disorganized 
communication and unusual thought content/delusional ideas) and their severity category (e.g. APS 
and BIPS). 
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Table 1  Sociodemographic and clinical characteristics of ultra-high risk (UHR) patients at baseline (n=35) 
 
Age: mean (sd); Mdn (range) 13.8 (2.1); 13.8 (9-17) 
Sex, male: n (%)  18 (51.4) 
1st- or 2nd-degree relative with psychosis: n (%) 4 (11.4) 
Verbal IQ: mean (sd); Mdn (range) 87.2 (17.3); 91 (53-129) 
Education (in years): mean (sd); Mdn (range) 8.4 (2.2); 8 (3-12) 
Urbanicity level, more than 2500 citizens: n (%) 25 (71.4) 
Duration of mental problems (in months): mean (sd); Mdn (range) 28.1 (28.2); 12 (2-120) 
SIPS sum scores: mean (sd); Mdn (range) 
Total SIPS 
Positive subscale (SIPS-P sum) 
Negative subscale (SIPS-N sum) 
Disorganization subscale (SIPS-D sum) 
General psychopathology subscale (SIPS-G sum) 
 
43.1 (14.6); 42 (12-80) 
12.2 (5.2); 13 (0-24) 
14.5 (6.4); 16 (1-29) 
6.5 (3.5);   6 (1-14) 
9.9 (4.3); 10 (1-18) 
UHR criterion: n (%) 
Any attenuated psychotic symptom (APS) 
 by unusual thought content/delusional ideas (P1=|3-5|) 
 by suspiciousness/persecutory ideas (P2=|3-5|) 
 by grandiosity (P3=|3-5|) 
 by perceptual abnormalities/hallucinations (P4=|3-5|) 
 by disorganized communication (P5=|3-5|) 
Any brief intermittent psychotic symptom (BIPS) 
 by unusual thought content/delusional ideas (P1=6) 
 by suspiciousness/persecutory ideas (P2=6) 
 by grandiosity (P3=6) 
 by perceptual abnormalities/hallucinations (P4=6) 
 by disorganized communication (P5=6) 
Any genetic risk plus functional decline (GRFD)  
 by 1st-degree relative with psychosis 
 by schizotypal personality disorder according to SIPS 
 
29 (82.9) 
20 (57.1)  
27 (77.1)  
5 (14.3)  
18 (51.4)  
13 (37.1) 
5 (14.3)  
1 (2.9)  
1 (2.9)  
0  
3 (8.6)  
0  
4 (11.4) 
3 (8.5) 
1 (2.9) 
Main axis-I DSM-IV disorder by K-SADS-PL: n (%) 
Any depressive disorder 
Any behavioural disorder 
Any anxiety disorder 
Any obsessive-compulsive disorder 
Any other disorder 
 
18 (51.4) 
7 (20.0) 
2 (5.7) 
5 (14.3) 
3 (8.6) 
C-GAS: mean (sd); Mdn (range) 48.6 (4.3); 50 (37-55) 
GF:Role: mean (sd); Mdn (range) 4.0 (0.7); 4 (3-5) 
GF:Social: mean (sd); Mdn (range) 4.1 (0.6); 4 (3-5) 
Cannabis use: n (%) 
Never  
Last (regular) use >1 month ago 
 
34 (97.2) 
1 (2.9) 
Current psychopharmacological medication: n (%) 
Any antidepressant 
Any benzodiazepine 
Any antipsychotic 
 
1 (2.9) 
1 (2.9) 
0 
SIPS: Structured Interview for Psychosis-Risk Syndromes (McGlashan et al., 2010); C-GAS: Childhood Global 
Assessment Scale (Schaffer et al., 1988); GF:Role: Global Functioning: Role (Niendam et al., 2006); GF:Social:  
Global Functioning: Social (Auther et al., 2006); K-SADS-PL: Schedule for Affective Disorders and Schizophrenia for 
School Aged Children, Present and Lifetime Version (Kaufman et al., 1997) 
Table 1
Table 2.  Results of univariate logistic regression analyses of effect of potential baseline predictors on 
conversion to psychosis  
Covariates  
(potential baseline predictors) 
E SE Wald (df) p Exp(E) lower 
95%-CI 
upper 
95%-CI 
Age (in yrs.) 0.057 0.205 0.078 (1) .781 1.059 0.708 1.583 
Main diagnosis (“other” as reference)   0.703 (4) .951    
Main diagnosis (anxiety) 21.203 23205.5  <0.001 (1) .999 >1000 0.000 - 
Main diagnosis (depressive) 19.950 23205.5 <0.001 (1) .999 >1000 0.000 - 
Main diagnosis (behavioural) 20.287 23205.5 <0.001 (1) .999 >1000 0.000 - 
Main diagnosis (obsessive-compulsive) <0.001 29352.8 0.000 (1) 1.0 1.000 0.000 - 
Urbanicity level a -0.206 0.246 0.700 (1) .403 0.814 0.502 1.318 
Education × age 0.002 0.009 0.051 (1) .822 1.002 0.984 1.020 
Education (in yrs.) 0.053 0.197 0.074 (1) .786 1.055 0.717 1.551 
Verbal IQ -0.042 0.028 2.236 (1) .135 0.959 0.907 1.013 
Sex (female) 1.204 0.920 1.714 (1) .190 3.333 0.550 20.217 
Family member with psychosis (any) -19.971 20096.5 <0.001 (1) .999 <0.001 0.000 - 
GF:Role -0.972 0.704 1.905 (1) .167 0.378 0.095 1.504 
GF:Social -0.811 0.738 1.208 (1) .272 0.444 0.105 1.887 
Duration of mental problems (in mths.) -0.055 0.037 2.118 (1) .146 0.947 0.880 1.019 
Any BIPS (present) 2.277 1.059 4.623 (1) .032 9.750 1.223 77.724 
BIPS by P1 (present) -19.853 40193.0 <0.001 (1) 1.0 <0.001 0.000 - 
BIPS by P2 (present) 22.743 40193.0 <0.001 (1) 1.0 >1000 .000 - 
BIPS by P3 (present) Not reported 
BIPS by P4 (present) 2.380 1.318 3.260 (1) .071 10.800 0.816 142.981 
BIPS by P5 (present) Not reported 
Any APS (present) -1.833 0.978 3.510 (1) .061 0.160 0.024 1.088 
APS by P1 (present) 20.584 10377.8 <0.001 (1) .998 >1000 0.000 - 
APS by P2 (present) 0.383 0.955 0.161 (1) .688 1.467 0.226 9.534 
APS by P3 (present) <0.001 1.208 <0.001 (1) 1.0 1.0 0.094 10.664 
APS by P4 (present) -0.431 0.853 0.255 (1) .613 0.650 0.122 3.457 
APS by P5 (present) 1.833 0.935 3.838 (1) .050 6.250 0.999 39.094 
Any GRD (present) -19.930 23205.4 <0.001 (1) .999 <0.001 0.000 - 
SIPS P1 score 0.334 0.286 1.362 (1) .243 1.397 0.797 2.447 
SIPS P2 score 0.438 0.417 1.105 (1) .293 1.550 0.685 3.507 
SIPS P3 score -0.377 0.426 0.784 (1) .376 0.686 0.297 1.581 
SIPS P4 score 0.278 0.280 0.984 (1) .321 1.320 0.763 2.285 
SIPS P5 score 0.674 0.308 4.800 (1) .028 1.963 1.074 3.588 
SIPS-P sum score 0.143 0.094 2.284 (1) .131 1.153 0.958 1.388 
SIPS-N sum score 0.036 0.069 0.271 (1) .603 1.036 0.906 1.186 
SIPS-D sum score 0.150 0.125 1.453 (1) .228 1.162 0.910 1.484 
SIPS-G sum score -1.626 1.102 2.177 (1) .140 1.024 0.842 1.245 
a in 5 ascending levels from 1=”less than 500 citizens” to 5=”more than 2500 citizens” 
Predictors that are significant at least at a statistical trend level (p<.10) are given in bold. 
 
Table 2
 Table 3.  Results of the univariate ordinal regression analyses of effects of potential predictors on 
outcome (conversion as reference value)  
Covariates 
(potential baseline predictors) 
Estimate SE Wald (df) p lower 
95%-CI 
upper 
95%-CI 
Age (in yrs.) 0.036 0.156 0.054 (1) .816 -0.269 0.341 
Main diagnosis (“other” as reference)       
Main diagnosis (anxiety) 2.363 1.818 1.689 (1) .194 -1.200 5.926 
Main diagnosis (depressive) 0.737 1.212 0.370 (1) .370 -1.638 3.113 
Main diagnosis (behavioural) 1.344 1.358 0.980 (1) .322 -1.318 4,007 
Main diagnosis (obsessive-compulsive) -0.207 1.410 0.022 (1) .883 -2.970 2,556 
Urbanicity level a 0.127 0.204 0.384 (1) .536 -0.274 0.527 
Education × age 0.002 0.007 0.078 (1) .780 -0.012 0.016 
Education (in yrs.) 0.045 0.149 0.091 (1) .753 -0.247 0.337 
Verbal IQ -0.024 0.020 1.526 (1) .217 -0.063 0.014 
Sex (female) 1.002 0.681 2.166 (1) .141 -0.332 2,336 
Family member with psychosis (none) -0.191 1.020 0.035 (1) .851 -2.191 1.809 
GF:Role -0.343 0.500 0.471(1) .493 -1.323 0.637 
GF:Social -0.160 0.538 0.089(1) .766 -1.216 0.895 
Duration of mental problems (in mths.) -0.019 0.012 2.276(1) .131 -0.043 0.006 
Any BIPS (absent) -1.822 0.989 3.398 (1) .065 -3.760 0.115 
BIPS by P1 (absent) Not calculated for unexpected singularities 
BIPS by P2 (absent) Not calculated for unexpected singularities 
BIPS by P3 (absent) Not reported 
BIPS by P4 (absent) -2.449 1.314 3.475 (1) .062 -5.023 0.126 
BIPS by P5 (absent) Not reported 
Any APS (absent) 1.503 0.904 2,762(1) .097 -0.270 3.276 
APS by P1 (absent) -1.905 0.775 6.046 (1) .014 -3.424 -0.387 
APS by P2 (absent) 0.668 0.784 0.726 (1) .394 -0.869 2.204 
APS by P3 (absent) -0.789 0.939 0.706 (1) .401 -2.629 1.051 
APS by P4 (absent) -0.024 0.649 0.001 (1) .970 -1.296 1.248 
APS by P5 (absent) -1.417 0.734 3.724 (1) .054 -2.856 0.022 
Any GRD (absent) -0.183 1.160 0.025(1) .875 -2.456 2.090 
SIPS P1 score 0.322 0.209 2,369(1) .124 -0,088 0,731 
SIPS P2 score 0.124 0.275 0.204(1) .652 -0.414 0.662 
SIPS P3 score 0.189 0.252 0.562(1) .453 -.306 0.684 
SIPS P4 score 0.303 0.203 2.235(1) .135 -0.094 0.700 
SIPS P5 score 0.423 0.206 4.210(1) .040 0.019 0.828 
SIPS-P sum score 0.131 0.069 3.577(1) .059 -0.005 0.267 
SIPS-N sum score 0.005 0.051 0.008(1) .929 -0,096  0,105 
SIPS-D sum score 0.101 0.095 1.127(1) .288 -0.085 0.287 
SIPS-G sum score 0.016 0.077 0.044(1) .834 -0.134 0.166 
a in 5 ascending levels from 1=”less than 500 citizens” to 5=”more than 2500 citizens” 
Predictors that are significant at least at a statistical trend level (p<.10) are given in bold. 
 
 
Table 3
 Table 4.  Result of the multivariate ordinal regression analysis of effect of potential predictors on 
outcome (conversion as reference value)  
Covariates, factors 
 
Estimate SE Wald (df) p lower 
95%-CI 
upper 
95%-CI 
SIPS-P5 score 0.174 0.484 0.129 (1) .720 -0.775 1.123 
SIPS-P sum score -0.023 0.117 0.039 (1) .843 -0.253 0.206 
No BIPS (any BIPS=0) 1.306 2.873 0.207 (1) .649 -4.325 6.936 
No APS (any APS=0) 1.682 2.374 0.502 (1) .479 -2.971 6.335 
No SIPS-P1 APS (P1-APS=0) -1.593 1.023 2.425 (1) .119 -3.598 0.412 
No SIPS-P4 BIPS (P4-BIPS=0) -1.938 1.986 0.952 (1) .329 -5830 1.954 
No SIPS-P5 APS (P5-APS=0) -0.870 1.606 0.294 (1) .588 -4.017 2.277 
 
Table 4
